Quick Answer
TG THERAPEUTICS, INC. reported Net Income Loss of $447.18 million for the year ending 2025.
- TG THERAPEUTICS, INC. showed an increase of +1,812.4% in Net Income Loss from 2024 to 2025.
- This data is from TG THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2011 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 8 years of available data (2011 to 2025), TG THERAPEUTICS, INC.'s Net Income Loss has grown by 52,519.7%.
- Historical annual values: Fiscal year 2025: $447.18 million | Fiscal year 2024: $23.38 million | Fiscal year 2023: $12.67 million | Fiscal year 2022: -$223.81 million | Fiscal year 2021: -$348.10 million | Fiscal year 2013: -$20.48 million | Fiscal year 2012: -$18.07 million | Fiscal year 2011: -$853.1 thousand.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: